GlycoMimetics

Acquired

Home - Crescent Biopharma

Gaithersburg, United States · Founded 2003 · $38.0M raised

Headquarters
Gaithersburg
Employees
11–50
Founded
2003
Business Model
B2B
Total Funding
$38.0M
Last Round
$38.0M Venture Round
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

GlycoMimetics was a Rockville, Maryland-based clinical-stage biotechnology company that discovered and developed glycobiology-based therapies targeting cancers and inflammatory diseases. Its leading program uproleselan targeted E-selectin in acute myeloid leukemia. In June 2025, GlycoMimetics merged with Crescent Biopharma.

Summary

GlycoMimetics is a Biotech company based in Gaithersburg, United States, founded in 2003. It has raised $38.0M in total across 1 round. Investors include Fairmount, Venrock and BVF Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to see all 3 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GlycoMimetics on Indexed.vc
<a href="https://indexed.vc/companies/glycomimetics"><img src="https://indexed.vc/api/badge/company/glycomimetics" alt="GlycoMimetics on Indexed.vc" width="260" height="76" /></a>